距离2026年春节仅剩一周，而第一批请假的人已开始提前过年。来自美团旅行的数据显示，春节酒店入住小高峰从2月7日开启，首批"请6休17"的游客率先 入住酒店，马年春节"酒店提前订"同比增长63%。 云南方面，截至2月上旬，云南春节文旅预订增速达54%。芒市网红体验"缅式洗头"热度上涨182%，网红大集"丙午街集市"热度上涨156%，当地美食"活螃 蟹"搜索量上涨123%，更多云南小城成为游客热衷探索的目的地。 小城玩法多 "反向过年"Top10黑马酒店目的地出炉 反向过年浪潮下，一线城市游客去秘境小城、少数民族聚居区寻找传统年味。美团旅行数据显示，云南普洱、德宏、保山、迪庆，成为春节一线城市游 客"反向过年"黑马酒店预订目的地。 游客青睐于这些小城，当然是因为其有区别于大城市的玩法。例如，去普洱景迈山徒步古茶林、去德宏赶集买1米长的"网红大豆荚"、去保山逛咖啡庄园、 去迪庆过藏历新年……更多小众、地道的在地体验，让游客"像本地人一样悠闲生活"，吸引一线城市游客"去小城过大年"。 春节家庭游热度高企、"反向过年"等新趋势频出，更多本地玩法成为吸引异地游客的金字招牌。美团旅行相关负责人表示，平台已上线"新春欢聚游 ...

Core Viewpoint - The announcement of spring and autumn holiday arrangements in various cities in Jiangsu Province is expected to boost travel demand and create new opportunities for the tourism market, particularly for family-oriented travel [1][3][4] Group 1: Spring Holiday Arrangements - Cities such as Nanjing, Suzhou, and Xuzhou have scheduled spring holidays from April 1 to April 3, aligning with the Qingming Festival to create a continuous 6-day holiday [1] - The arrangement is designed to facilitate family travel, with schools providing childcare services for families facing difficulties [3] Group 2: Autumn Holiday Arrangements - The autumn holiday in cities like Yangzhou and Lianyungang is planned to connect with weekends in November, creating extended breaks of up to 5 days [2] - This structure aims to enhance travel opportunities during the autumn season, with specific dates to be confirmed later [2] Group 3: Travel Demand Insights - Following the announcement, there was a significant increase in search volume for travel-related keywords, with over a 120% rise in interest for spring travel and family trips [2] - Popular destinations include warm climates suitable for family vacations, such as Sanya, Xishuangbanna, and overseas locations like South Korea and Malaysia [2] Group 4: Policy Implications - The integration of school holidays with paid leave for workers is seen as a strategic move to alleviate travel congestion during peak periods and promote a new tourism product ecosystem [3][4] - Various provinces are exploring similar holiday arrangements, indicating a broader trend towards flexible holiday scheduling to enhance consumer spending and travel opportunities [4]

近日，同程旅行推出"9元起抽春节酒店盲盒"活动，以"低成本+社交助力+多场景适配"的创新玩法，为 旅客打造高性价比住宿体验。截至2月8日，已有超10万用户参与该活动。活动将持续至2月14日，用户 抽取的盲盒酒店产品最晚入住时间为2月23日。 本次春节酒店盲盒活动打造了阶梯式盲盒产品矩阵，可覆盖春节期间各类住宿场景，满足不同用户的需 求。其中，"9元中转歇脚盲盒"专为春节假期出行旅客设计，部分酒店紧邻机场、高铁站等交通枢纽， 成为本次活动的爆款产品。"99元冬日限定"盲盒产品，则包含浪漫约会、全家聚会、冬日限定三大主 题，分别适配情侣出游、家庭团聚、冰雪和避寒旅游等场景，满足假期多元化住宿需求。 同程旅行数据显示，本次春节酒店盲盒的热门参与城市与假期出行趋势高度契合。"9元中转歇脚盲 盒"的热门解锁城市集中在广州、长沙、深圳、北京、成都等，这些城市也是用户春节假期出行的热门 始发地与目的地，"99元冬日限定"盲盒则在三亚、海口、昆明、哈尔滨、长春等避寒和冰雪旅游城市备 受欢迎。 参与抽取盲盒的用户中，90后和00后用户合计占比超过75%。在"反向过春节"的趋势下，部分70后用户 参与抽取"99元全家聚会盲盒"的 ...

在返程出行热度高涨的同时，热门城市机场和火车站周边的酒店和钟点房产品预订热度也出现大幅提 升。同程旅行数据显示，截至2月8日，入住时间在正月初六的一线城市机场和火车站周边酒店搜索热 度，相比上周同期增长超1倍。北京南站、上海虹桥站、成都东站、深圳北站、重庆北站附近的部分酒 店钟点房产品相对紧俏。（编辑：陈虹莹 校对：李佳洹 审核：程凌） 《中国民航报》、中国民航网 记者许晓泓 报道：2月8日，正月初六（2月22日）火车票正式开售，带动 出行热度明显走高。同程旅行数据显示，截至2月8日，预订正月初六出行的国内机票中，一线城市及省 会城市为热门目的地，其中成都市位居国内机票预订热门出发地和目的地前二。务工、商旅及旅行返程 人群是国内机票的预订主力。正月初六出行的国内热门航线TOP5为：成都—上海、重庆—深圳、昆明 —上海、贵阳—北京、西安—深圳。 同程旅行数据显示，预计从正月初六开始迎来春节假期返程高峰。在预订正月初六出行的国内机票用户 中，"80后""90后""00后"合计占比超过70%。国内机票预订热度最高的十大出发地为：成都、重庆、昆 明、贵阳、西安、北京、郑州、长沙、广州、上海；国内机票预订热度最高的十大 ...

Group 1: Meituan's Acquisition of Dingdong Maicai - Meituan announced the acquisition of Dingdong Maicai's China business for approximately $717 million (about 4.98 billion RMB) on February 5, 2026[1] - Dingdong Maicai's market value was $694 million (approximately 4.82 billion RMB) prior to the announcement[1] - Dingdong Maicai has achieved a historical high in revenue and GMV in Q3 2025, with revenue of 6.66 billion RMB and GMV of 7.27 billion RMB, marking seven consecutive quarters of GAAP profitability[1][11] Group 2: Ctrip's Spring Festival Travel Forecast - Ctrip's 2026 Spring Festival travel forecast indicates that family travel will account for over 50% of bookings, with Nanjing emerging as a popular destination during the holiday[2] - The number of pre-orders for travel to Shantou increased by 186% year-on-year, leading the list of emerging destinations[2][14] - The average price of family rooms is 9% higher than other room types, reflecting the growing demand for family-oriented travel[2][15] Group 3: Regulatory Standards for Prepared Dishes - The National Health Commission proposed a standard for prepared dishes, stating that the shelf life should not exceed 12 months and that preservatives are prohibited[3][22] - The standard aims to align with public consumption habits and ensure the safety and nutritional quality of prepared dishes[3][22] - The use of food additives should be minimized, and only those necessary for production should be allowed[3][23]

Group 1: Meituan's Acquisition of Dingdong Maicai - Meituan announced the acquisition of Dingdong Maicai for approximately $717 million (about 4.98 billion RMB), acquiring 100% of its China business while the overseas operations will be divested before the transaction closes [1][10] - Dingdong Maicai, founded in 2017, focuses on fresh produce delivery within 29 minutes and has expanded rapidly during the pandemic, increasing its front warehouses from 550 in 2019 to nearly 1,400 by the end of 2021 [1][10] - The acquisition aligns with both companies' development philosophies, leveraging strengths in product offerings, technology, and operations, with Dingdong Maicai expected to enhance its market position amid competition in the East China market [1][12] Group 2: Ctrip's 2026 Spring Festival Travel Market Forecast - Ctrip's forecast indicates that the Spring Festival travel market in 2026 is expected to set a record for the "hottest Spring Festival," driven by factors such as extended holidays and a surge in family travel, with family trips accounting for over half of the bookings [2][22] - Southern cities dominate the list of emerging travel destinations, with Shantou leading the growth in bookings with a 186% year-on-year increase, followed by other southern cities experiencing significant growth [2][15] - The trend of "reverse Spring Festival travel" is gaining traction, with international tourists showing increased interest in experiencing the Chinese New Year, particularly from countries like Russia and South Korea, with booking increases of 471% and 95% respectively [2][21] Group 3: National Standards for Prepared Dishes - The National Health Commission has released a draft standard for prepared dishes, which prohibits the use of preservatives and sets a maximum shelf life of 12 months for these products [3][24] - The standard aims to address public concerns regarding the shelf life of prepared dishes, ensuring that they maintain quality and flavor, which are key consumer expectations [5][24] - It emphasizes minimizing the use of food additives, requiring that they do not compromise the nutritional value of the food and are only used when necessary [6][25]

Investment Rating - The report indicates a positive outlook for the pharmaceutical sector, particularly for innovative drugs and companies expected to reach profitability in 2025 [1][9][15]. Core Insights - The innovative drug sector is anticipated to see significant growth due to the commercialization of core products and contributions from business development (BD) revenues, with companies like BeiGene, Innovent Biologics, and others expected to achieve profitability [1][9]. - The Pharma sub-sector is projected to experience a revenue growth rate of 15-20% in 2025, with notable companies such as Hansoh Pharmaceutical and China Biologic Products leading this growth [2][10]. - The CXO sector is also expected to report strong performance, with companies like WuXi AppTec forecasting substantial revenue and profit increases [3][11]. - The medical services sector is currently valued at historical lows, with a projected revenue growth of 13% for Genscript Biotech, highlighting the importance of monitoring industry changes [4][12]. Summary by Sections Innovative Drugs - Companies expected to achieve profitability in 2025 include BeiGene, Innovent Biologics, and others, driven by increased commercialization and BD revenues [1][9]. Pharma - Revenue growth of 15-20% is expected for leading companies such as Hansoh Pharmaceutical and China Biologic Products, with a significant boost anticipated for 3SBio due to a major BD deal with Pfizer [2][10]. CXO - WuXi AppTec is projected to achieve approximately 454.56 billion RMB in revenue, reflecting a year-on-year growth of about 15.84%, with adjusted net profits expected to rise significantly [3][11]. Medical Services - Genscript Biotech is expected to see a revenue increase of 13% in 2025, emphasizing the need to focus on overseas business expansion and AI integration in traditional medicine [4][12].

Investment Rating - The report maintains a positive outlook on the pharmaceutical sector, indicating an "Overweight" rating for the industry, suggesting it will outperform the overall market [1]. Core Insights - The report highlights that the commercialization of innovative drugs, combined with licensing income, is expected to lead to profitability for several companies in 2025, including BeiGene, Innovent Biologics, and others [1][9]. - The Pharma sub-sector is projected to achieve a revenue growth rate of 15-20% in 2025 for companies like Hansoh Pharmaceutical and China Biologic Products, with a significant revenue increase expected for 3SBio due to a major business development deal with Pfizer [2][10]. - The CXO sector is also expected to show strong performance, with companies like WuXi AppTec forecasting a revenue increase of approximately 15.84% and a net profit growth of about 102.65% in 2025 [3][11]. - In the medical services sector, the report notes that valuations are at historical lows, with a projected revenue growth of 13% for GuoShengTang in 2025, emphasizing the importance of overseas business expansion and AI integration in traditional Chinese medicine [4][12]. Summary by Sections Innovative Drugs - The report anticipates that several innovative drug companies will reach profitability in 2025 due to increased commercialization and business development income [9][15]. Pharma - The Pharma sub-sector is expected to see a revenue growth of 15-20% in 2025 for key players, with 3SBio projected to achieve over 100% growth due to a significant partnership with Pfizer [2][10]. CXO - WuXi AppTec is expected to report a revenue of approximately 454.56 billion RMB in 2025, with a net profit growth of around 102.65% [3][11]. Medical Services - GuoShengTang is projected to have a revenue growth of 13% in 2025, with a focus on overseas acquisitions and AI applications in traditional medicine [4][12].

Investment Rating - The report does not explicitly provide an investment rating for the company [5]. Core Insights - The report aligns with the views of CITIC Lyon Research, indicating that the risk of AI replacing online travel agencies (OTAs) is not imminent in China due to stricter supply chain control by OTAs [5]. - The hotel management business is expected to contribute more significantly to revenue growth in 2026, although it may come with increased initial expenditures [5]. - The impact of Google's new flight booking feature on the global OTA sector is viewed as narrative-driven, with limited effects anticipated in the Chinese market due to local OTAs' advantages [5]. - The report highlights that the market risk appetite has notably decreased, despite the potential benefits from the hotel management business [5]. Revenue and Business Segmentation - The revenue from transportation ticketing services accounts for 50.7%, while accommodation booking services contribute 32.8%, and other services make up 16.5% [10]. - The company primarily serves users in low-tier cities in China, offering services such as accommodation booking, transportation ticketing, and online advertising [9]. Market Dynamics - The report notes that the ongoing antitrust investigation into Ctrip has increased market attention on the company, but it argues that this logic is flawed as both companies share a hotel inventory pool [6]. - Approximately 60-70% of the hotel transaction volume on the company's platform comes from Ctrip's inventory, suggesting limited benefits from any changes in Ctrip's commission structure [6]. - The competitive landscape in the Chinese OTA market is intensifying, with potential risks to profit margin expansion remaining uncertain until the outcomes of the Ctrip investigation are clearer [6]. Catalysts - Upcoming financial reports and guidance, particularly regarding profit margins, as well as travel data around major holidays, mergers, and capital allocation strategies are identified as key catalysts [7].

每年春节假期都是阖家团圆、带娃旅行的热门时段。临近春节假期，飞猪数据显示，近两周，上海乐高 乐园相关商品的预订规模环比上月增长超65%。 据悉，今年春节假期，飞猪、高德与上海乐高乐园度假区将基于"大过年就要大快乐"主题活动展开联合 营销活动。活动期间，高德地图App将上线上海乐高乐园度假区"一键智慧游"，同时全面升级上海乐高 乐园度假区专属页面。消费者可以在这里优惠购票、购买来自飞猪官方旗舰店的门票商品，享受智能游 园导览服务，还能完成园区打卡任务赢得纪念礼物、免费领取专属乐高积木小车标，让前来度假的家庭 感受到线上线下（300959）跨端互动和"一站式"旅游的乐趣。 高德旅游业务负责人黄鹏表示："高德始终以'AI空间智能提升用户旅行全程体验'为核心。此次深度三 方合作，是高德为春节文旅市场交出的一份暖心答卷，更是高德在文旅领域深化'线上+线下'融合的重 要实践。" 本报讯(记者梁傲男)2月5日，飞猪、高德与上海乐高乐园度假区签署战略合作协议，三方将围绕品牌营 销、园区智能导览、IP运营等方面深入合作，为消费者打造更贴心更优惠的行前、行中、行后服务。 根据协议，飞猪将统筹策划全年的三方联合营销活动，同时升级上 ...